Group One Trading, L.P. Galera Therapeutics, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.14 - $0.27 $4,504 - $8,687	-32,177 Reduced 49.58%	32,720 $4,000
Q3 2023 Nov 09, 2023	SELL	$0.17 - $3.0 $1,664 - $29,370	-9,790 Reduced 13.11%	64,897 $11,000
Q2 2023 Aug 09, 2023	BUY	$2.5 - $3.42 $186,717 - $255,429	74,687 New	74,687 $233,000
Q4 2022 Feb 09, 2023	BUY	$1.34 - $1.78 $3,430 - $4,556	2,560 Added 300.12%	3,413 $5,000
Q3 2022 Nov 09, 2022	BUY	$1.15 - $2.1 $980 - $1,791	853 New	853 $1,000
Q2 2022 Aug 11, 2022	SELL	$1.24 - $2.39 $42,597 - $82,103	-34,353 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.01 - $4.19 $68,926 - $143,683	-34,292 Reduced 49.96%	34,353 $82,000
Q4 2021 Feb 11, 2022	BUY	$1.27 - $8.28 $87,179 - $568,380	68,645 New	68,645 $315,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.34M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.